Beijing, China

Guohua Chi

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Jiangsu Kangbeide Pharmaceuticals Co. Ltd.. Active years: 2016.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Guohua Chi: Innovator in Transdermal Drug Delivery Systems

Introduction

Guohua Chi is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of transdermal drug delivery systems. His innovative work has led to advancements that enhance the efficacy of drug formulations.

Latest Patents

Guohua Chi holds a patent for a transdermal patch containing Rotigotine. This patent describes a Rotigotine-containing composition that features a matrix mixture system formed from polyvinylpyrrolidone and a combination of acrylic and silicone pressure-sensitive adhesives. The formulation includes specific percentages of each component, ensuring improved solubility, release, and initial penetration levels of Rotigotine. The composition is designed to optimize the therapeutic effects of the drug while providing a user-friendly delivery method.

Career Highlights

Chi is associated with Jiangsu Kangbeide Pharmaceuticals Co. Ltd., where he has been instrumental in advancing pharmaceutical technologies. His work has not only contributed to the company's portfolio but has also positioned it as a leader in innovative drug delivery solutions.

Collaborations

Guohua Chi has collaborated with notable colleagues, including Huiyong Xue and Enhong Zhang. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the quality of their research and development efforts.

Conclusion

Guohua Chi's contributions to the field of transdermal drug delivery systems exemplify the impact of innovation in pharmaceuticals. His work continues to pave the way for more effective treatment options, benefiting patients worldwide.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…